Literature DB >> 32421977

Inflammation, NF-κB, and Chronic Diseases: How are They Linked?

Ajaikumar B Kunnumakkara1, Bano Shabnam1, Sosmitha Girisa1, Choudhary Harsha2, Kishore Banik1, Th Babita Devi2, Ruplekha Choudhury2, Henamayee Sahu2, Dey Parama2, Bethsebie L Sailo1, Krishan Kumar Thakur1, Subhash C Gupta3, Bharat B Aggarwal4.   

Abstract

Most chronic diseases, caused by lifestyle factors, appear to be linked to inflammation. Inflammation is activated mechanistically, and nuclear factor-κB (NF-κB) is a significant mediator. NF-κB, one of the most studied transcription factors, was first identified in the nucleus of B lymphocytes almost three decades ago. This protein has a key function in regulating the human immune system, and its dysregulation has been linked to many chronic diseases including asthma, cancer, diabetes, rheumatoid arthritis, inflammation, and neurological disorders. Physiologically, many cytokines have been discovered that activate NF-κB. Pathologically, environmental carcinogens such as cigarette smoke, radiation, bacteria, and viruses can also activate this transcription factor. NF-κB activation controls expression of more than 500 genes, and most are deleterious to the human body when dysregulated. More than 70,000 articles have been published regarding NF-κB. This review emphasizes the upside and downside of NF-κB in normal and disease conditions and the ways in which we can control this critical transcription factor in patients.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32421977     DOI: 10.1615/CritRevImmunol.2020033210

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  32 in total

Review 1.  Redox Homeostasis in Poultry: Regulatory Roles of NF-κB.

Authors:  Peter F Surai; Ivan I Kochish; Michael T Kidd
Journal:  Antioxidants (Basel)       Date:  2021-01-28

2.  The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells.

Authors:  Bingyi Tan; Zenong Yuan; Qingyu Zhang; Xu Xiqiang; Jun Dong
Journal:  J Appl Biomed       Date:  2021-09-24       Impact factor: 1.797

Review 3.  The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

Authors:  Elina Khatoon; Mangala Hegde; Aviral Kumar; Uzini Devi Daimary; Gautam Sethi; Anupam Bishyaee; Ajaikumar B Kunnumakkara
Journal:  Arch Pharm Res       Date:  2022-08-20       Impact factor: 6.010

4.  The Effect of TLR9, MyD88, and NF-κB p65 in Systemic Lupus Erythematosus.

Authors:  Huanan Wang; Feng Guo; Min Wang; Tingting Wang; Shanzhi Wang; Yanni Huang; Feng Ye
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-13       Impact factor: 2.650

5.  The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults.

Authors:  Hossein Farhadnejad; Asal Neshatbini Tehrani; Mitra Kazemi Jahromi; Farshad Teymoori; Ebrahim Mokhtari; Ammar Salehi-Sahlabadi; Parvin Mirmiran
Journal:  BMC Gastroenterol       Date:  2022-05-29       Impact factor: 2.847

Review 6.  Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis.

Authors:  Anna-Lena Mueller; Aranka Brockmueller; Ajaikumar B Kunnumakkara; Mehdi Shakibaei
Journal:  Nutrients       Date:  2022-05-12       Impact factor: 6.706

Review 7.  COVID-19, cytokines, inflammation, and spices: How are they related?

Authors:  Ajaikumar B Kunnumakkara; Varsha Rana; Dey Parama; Kishore Banik; Sosmitha Girisa; Sahu Henamayee; Krishan Kumar Thakur; Uma Dutta; Prachi Garodia; Subash C Gupta; Bharat B Aggarwal
Journal:  Life Sci       Date:  2021-02-16       Impact factor: 5.037

8.  Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer.

Authors:  Shirley James; Jayasekharan S Aparna; Anu Babu; Aswathy Mary Paul; Manendra Babu Lankadasari; Subha R Athira; Sreesha S Kumar; Yadu Vijayan; Narayanan N Namitha; Sabira Mohammed; Girijadevi Reshmi; Kuzhuvelil B Harikumar
Journal:  Biomolecules       Date:  2021-04-29

Review 9.  Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Muhammad Imran; Abdur Rauf; Muhammad Nadeem; Tanweer Aslam Gondal; Bashir Ahmad; Muhammad Atif; Mohammad S Mubarak; Oksana Sytar; Oxana Mihailovna Zhilina; Ekaterina Robertovna Garsiya; Antonella Smeriglio; Domenico Trombetta; Daniel Gabriel Pons; Miquel Martorell; Susana M Cardoso; Ahmad Faizal Abdull Razis; Usman Sunusi; Ramla Muhammad Kamal; Lia Sanda Rotariu; Monica Butnariu; Anca Oana Docea; Daniela Calina
Journal:  Oxid Med Cell Longev       Date:  2021-07-19       Impact factor: 6.543

10.  Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells.

Authors:  Dina Morein; Linor Rubinstein-Achiasaf; Hadar Brayer; Orly Dorot; Edward Pichinuk; Hagar Ben-Yaakov; Tsipi Meshel; Metsada Pasmanik-Chor; Adit Ben-Baruch
Journal:  Cells       Date:  2021-05-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.